Gc isoforms of the vitamin D binding protein did not modify the association between circulating vitamin D and cancer risk within the PLCO Trial, either for overall cancer or specific cancer sites such as lung, colorectum, breast and prostate, although an interaction was noted for bladder cancer. The gene discussed is GC; the disease is urinary bladder carcinoma.